https://www.selleckchem.com/products/as101.html
OLT could achieve a longer life expectancy, but it was greatly affected by the dropout rate while waiting for the liver donor. RFA was preferred when the willingness to pay (WTP) 2,5000 RMB/QALY, OLT was preferred when WTP 75,000 RMB/QALY, and HR was preferred when WTP was between the two. HR in SHC with OLT had the longest life expectancy, but due to the limitations of organ sources, OLT was the preferred treatment option when the WTP was large enough, and the difference in the efficacy and cost-effectiveness between the HR and